Key facts
- Fellow’s last known valuation is $75.0M (Jul 2025).
- It has raised $53.5M; the latest was Later Stage VC ($24.0M) in Jul 2025.
- Notable investors include Great Oaks Venture Capital, Mantis VC, Human Capital, Offline Ventures, Labcorp Venture Fund — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Fellow
- ·The full record, as it builds
Funding rounds
No funding rounds for Fellow are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Fellow
Developer of a man's fertility analysis kit designed to offer lab-grade results that a physician approves. The company's kit offers a convenient and complete fertility test for men, where a sample is sent to the company's lab, after which it is analyzed to provide an understanding of the user's ability to conceive, enabling the user to understand the health of their fertility while skipping the uncomfortable clinic experience.
- Sector
- Healthcare
- HQ
- San Leandro, CA, United States
- Founded
- 2018
- Employees
- 74
- Website
- meetfellow.com/
- Ownership
- Privately Held (backing)
Fellow doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Fellow shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Fellow in its N-PORT filings yet. We sweep new filings monthly.